Ribosomal protein L29 pseudogene 7 (RPL29P7)

Ribosomal protein L29 pseudogene 7 (RPL29P7) is a processed pseudogene related to the gene encoding 60S ribosomal protein L29, found in the human genome[2]. Pseudogenes like RPL29P7 are nonfunctional genomic DNA sequences similar to functional genes but typically lack protein-coding capability, and thus do not produce an active ribosomal protein. RPL29P7 is included in genomic databases as a pseudogene, and while ribosomal protein L29 itself is an essential component of the 60S ribosomal subunit involved in protein synthesis, none of the functional characteristics of RPL29 can be ascribed to RPL29P7, which encodes no functional RNA or protein product[1][2][3]. The "ribosomal protein L29" protein (RPL29) is a component of the large ribosomal 60S subunit, critical for protein synthesis[1][3][8]. In contrast, RPL29P7 is a processed pseudogene—one of several pseudogenes for RPL29 distributed throughout the human genome[2]. According to the HUGO Gene Nomenclature Committee (HGNC), RPL29P7 is officially recognized as a pseudogene, not a functional gene or therapeutic target[2]. Pseudogenes are sometimes transcribed but rarely produce functional proteins and are not regarded as drug targets. There is no evidence or publication indicating RPL29P7 serves as a biomarker, is implicated in disease, or is the subject of pharmacological intervention. RPL29P7 is not a protein-coding gene, receptor, enzyme, transporter, or other classical therapeutic target. Its listing as a "pseudogene" means it is essentially a nonfunctional genomic element. For structured target information, true/functional "ribosomal protein L29" (RPL29), not RPL29P7, would be the molecule of interest for research or pharmacological targeting[1][2][3].